Stock screenerAll disclosures →
EDGAR →
PMN
Conviction 82HealthcareScan · Mon, Aug 10, 2026PMN$14.54-1.16%
ResistanceSupportVol 14Insider buyVol MA14 218.96K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price14.54
Change-1.16%
Gap+1.90%
Rel volume2.32×
Avg volume201.92K
Avg $ vol2.88M
SMA 2013.86
SMA 5012.29
SMA 20010.82
Price vs 50+18.33%
Price vs 200+34.40%
MA stackbullish
50/200 cross—
Supertrenddown · 16.02
RSI (14)56
MACD hist-0.03
MACD cross—
Stoch %K / %D55 / 49
ADX (14)34
+DI / −DI31 / 13
RSI divergence—
MACD divergence—
ATR %+9.22%
ADR %10.87%
52w high24.79
52w low0.2895
From 52w high-41.35%
Above 52w low+4922.45%
New 52w highNo
SqueezeOff
Bollinger width26.07%
%B0.69
Donchian pos54.83%
Donchian high17.25
Donchian low11.25
AVWAP (52w high)13.99
vs AVWAP high+3.95%
AVWAP (52w low)13.61
vs AVWAP low+6.86%
OBV trendFlat
Chaikin MF (20)-0.20
Today vs 20d2.32×
Avg vol (14d)218.96K
Avg vol (20d)201.92K
Avg $ vol (20d)2.88M
Market cap130.39M
RS 3m (vs SPY)+43.95%
RS 6m (vs SPY)-1.82%
RS line new highNo
Trend template6/8
Technical rank83.7
1 week+2.83%
1 month+2.04%
3 months+47.91%
6 months+14.22%
1 year+2543.16%
YTD+103.78%
P/E-3.28
P/B2.15
P/S—
P/FCF-4.64
EPS-22.61
Div yield—
ROE-65.42%
ROA-58.92%
Debt/Eq0.00
Current9.92
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-1529.33%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value66.58M
Revenue—
Net income-8.24M
Gross profit—
Free cash flow-28.12M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out8.97M
Employees11
ListedFri, Sep 30, 2005
Free float7.88M
Float %87.9%
Short interest235.78K
Days to cover3.1d
Short volume60.1%
Squeeze score50 / 100
Next earningsThu, Aug 13, 2026 · after (3d)
EPS forecast−$1.45 · 3 est
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank83.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.97
Support10.70
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PMN
No recent disclosed trades by Congress in PMN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PMN · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kaplan Johanne Chief Development Officer · Common Shares · 2026-08-05 | Buy | 2.28K | $30K | 2026-08-05 | 2026-08-07 |
Mandel-Brehm Josh Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
Kaplan Johanne Chief Development Officer · Option (right to buy) · 2026-05-20 | Grant | 50K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Warma Neil K Chief Executive Officer · Option (right to buy) · 2026-05-20 | Grant | 160K | $0 | 2026-05-20 | 2026-05-22 |
Williams Eugene Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Milbury Max A. Principal Accounting Officer · Option (right to buy) · 2026-05-20 | Grant | 18.17K | $0 | 2026-05-20 | 2026-05-22 |
Alex Slanix Paul Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Shafmaster Madge K. Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in PMN · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.